Statins are HMG-CoA reductase inhibitors, the most-prescribed class of cholesterol-lowering drugs in the United States. The three largest-selling statins by prescription volume are atorvastatin (brand name Lipitor), rosuvastatin (brand name Crestor), and simvastatin (brand name Zocor). All three have been off-patent for years and are available as cheap FDA-approved generics. Generic atorvastatin became available in November 2011, generic simvastatin in 2006, and generic rosuvastatin in 2016 after AstraZeneca's last Crestor patent expired. Because all three are now generic, the actual 2026 cash price for any of them ranges from $4 to $15 per month at most major pharmacy chains, with Walmart offering atorvastatin and simvastatin at $4 per month through its $4 Generic Prescription Program.
Despite the low generic prices, hospital inpatient bills routinely show statin charges of $50 to $300 per tablet due to facility-rate markups that bundle the drug acquisition cost with nursing administration, pharmacy handling, and overhead fees. Patients who receive brand-name Lipitor or Crestor without insurance face retail cash prices of $300 to $700 per month. For those patients, two manufacturer-run patient assistance programs can provide the brand drugs at no cost: Pfizer RxPathways for Lipitor, and AstraZeneca's AZ&Me program for Crestor. Both programs use a 300 percent of the federal poverty level income threshold for uninsured and government-insured patients. Commercially insured patients are not eligible for these programs. For commercially insured patients denied coverage, a formulary exception or step-therapy override is the standard first step before appealing.
Atorvastatin remains the workhorse statin for most patients because it offers the strongest LDL reduction per dollar. Rosuvastatin (generic Crestor) is slightly more potent at equivalent doses and preferred for patients who need maximum LDL reduction or have interactions with atorvastatin's cytochrome P450 3A4 metabolism pathway. Simvastatin is the oldest commonly prescribed statin and is primarily used in patients already stabilized on it; the FDA placed an 80 mg dose warning in 2011 due to myopathy risk, making atorvastatin and rosuvastatin preferred for high-intensity statin therapy. None of the three statins is subject to IRA Medicare price negotiation as of 2026 because all are generic and available at low cost without negotiation. Under Medicare Part D, all three fall under the general 2026 annual $2,100 out-of-pocket cap established by the Inflation Reduction Act of 2022.
What Statins Comparison Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same statins comparison can cost many times more at a hospital than at your local pharmacy:
2026 Statins Comparison Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Walmart $4 Generic Program (atorvastatin, simvastatin) | $4 / 30-day supply (no insurance needed) | Covers atorvastatin and simvastatin at most dose strengths. Rosuvastatin is available at Walmart via GoodRx coupon for approximately $9 per month. |
| Retail pharmacy with GoodRx coupon | $4 - $25 / 30-day supply | All three generic statins are available for under $25 per month with a free GoodRx, SingleCare, or pharmacy savings-club coupon at Costco, Kroger, CVS, and Walgreens. |
| Brand-name retail (Lipitor, Crestor, Zocor without insurance) | $300 - $700 / 30-day supply | Brand Lipitor (atorvastatin) retails at $430 to $700 per month; brand Crestor near $300 to $420; brand Zocor near $250 to $400. Ask your pharmacist for the generic equivalent. |
| Medicare Part D (2026) | $0 - $5 / month copay (Tier 1 generic) | All three generic statins are Tier 1 preferred generics on nearly every Medicare Part D plan. Subject to the 2026 annual $2,100 Part D out-of-pocket cap. No prior authorization for standard cardiovascular doses. |
| Medicaid | $1 - $4 / prescription | All three generic statins are covered as preferred generics in all 50 states. Copay varies by state; some states charge $0 for preferred generics. |
| Inpatient hospital charge | $50 - $300 / tablet | Facility-rate markup for oral statins. A drug acquired for under $0.50 per tablet can appear at $50 to $300 per dose on an inpatient itemized bill. |
Statins are oral Part D drugs with no Medicare Part B ASP rate and no J-codes. Retail prices reflect 2026 GoodRx and SingleCare data. Walmart $4 price requires no coupon for atorvastatin and simvastatin. Inpatient ranges reflect CMS Hospital Price Transparency chargemaster data.
Source: GoodRx 2026, SingleCare 2026, Walmart $4 Prescription Program, CMS Hospital Price Transparency, Medicare Part D formularies
Why Hospitals Charge So Much
Hospitals bill oral medications at facility rates that bundle the drug acquisition cost with markup for nursing administration, pharmacy dispensing, storage, and overhead. Generic atorvastatin that the hospital acquires for under $0.50 per tablet can appear on an itemized inpatient bill at $50 to $300 per dose. A 7-day hospital stay continuing a patient's home statin regimen at one tablet per day can produce a $350 to $2,100 statin line item on the hospital bill for a drug that costs $4 per month at the corner pharmacy. Hospitals are required by CMS Hospital Price Transparency rules to publish their chargemaster rates, but those published rates are starting prices, not final negotiated amounts.
Because statins have no Medicare Part B ASP rate (they are oral Part D drugs), there is no single federal benchmark price that inpatient bills must honor. Patients can challenge inflated statin charges by requesting an itemized bill, looking up the National Drug Code (NDC) on the bill, and comparing the charge to the retail generic cash price. Charges more than 100 times above the retail generic price are standard dispute targets. Requesting a reduction to cost plus a reasonable pharmacy administration fee is a common and frequently successful approach for billing departments at hospitals that have financial hardship or charity care programs.
A common scenario: a patient admitted for a cardiac catheterization continues atorvastatin 40 mg daily during the hospital stay. The hospital dispenses the same generic tablet available for $4 per month at Walmart. The inpatient bill shows $80 per tablet for 3 days, totaling $240 in atorvastatin charges. That $240 charge for a drug costing less than $0.50 per tablet to acquire is a standard dispute target. The CoveredUSA Medical Bill Analyzer flags statin charges above $10 per tablet as automatic review items, and most patients who challenge these charges obtain a reduction.
Patient Assistance Programs
Both Pfizer (maker of brand Lipitor) and AstraZeneca (maker of brand Crestor) run manufacturer patient assistance programs for uninsured and government-insured patients who cannot afford the brand-name statin. For uninsured patients who can take generic statins, the $4 generic at Walmart is cheaper than any PAP and requires no application. The PAPs below are relevant only if your prescriber has documented a clinical need for the brand-name product and generic statins are not clinically appropriate.
Patient assistance programs for Statins Comparison| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Pfizer RxPathways Patient Assistance Program (Lipitor) | Free brand-name Lipitor for uninsured and government-insured patients with household income at or below 300% FPL | pfizerrxpathways.com |
| AstraZeneca AZ&Me Prescription Savings Program (Crestor) | Free brand-name Crestor for uninsured patients with household income at or below 300% FPL for primary care products | azandme.com |
| NeedyMeds Drug Discount Card | Variable discount on generic and brand statins at most US pharmacies, accepted regardless of income or insurance status | needymeds.org |
| GoodRx Free Coupon | Reduces generic statin cash prices to $4 to $25 per month at most major chains; free to use with no application required | goodrx.com |
Manufacturer savings cards and PAPs are not available to commercially insured patients for Pfizer RxPathways or AZ&Me. Federal anti-kickback statute (42 U.S.C. Section 1320a-7b) bars manufacturer copay cards from Medicare, Medicaid, TRICARE, and VA beneficiaries. If you have government insurance and cannot afford your statin copay, use the Pfizer RxPathways or AZ&Me income-based PAP instead. For most patients on Medicare Part D, generic atorvastatin or rosuvastatin will be on Tier 1 with a $0 to $5 copay, making the PAP unnecessary.
Source: Pfizer RxPathways (pfizerrxpathways.com), AstraZeneca AZ&Me (azandme.com), NeedyMeds (needymeds.org)
Medicare Part D
Generic atorvastatin, rosuvastatin, and simvastatin are all covered by Medicare Part D plans. All three are placed on Tier 1 (preferred generic) or Tier 2 (generic) on virtually every Part D formulary, with copays of $0 to $5 per month. There is no drug-specific monthly cap for statins under the Inflation Reduction Act. Statin spending falls under the general 2026 Medicare Part D annual out-of-pocket cap of $2,100, after which you pay $0 for all covered drugs for the rest of the calendar year. Because generic statins are so inexpensive, you are extremely unlikely to reach the $2,100 cap from statin spending alone.
Statins are not subject to IRA Medicare price negotiation and no statin has a Maximum Fair Price under the Inflation Reduction Act of 2022. The IRA negotiation program targets brand-name drugs without generic competition that account for high Medicare spending. Because atorvastatin, rosuvastatin, and simvastatin are already available as inexpensive generics, they do not qualify for and do not need a negotiated Maximum Fair Price. Brand Lipitor, Crestor, and Zocor remain on some Part D formularies as Tier 3 or Tier 4 drugs, but no patient needs to pay $300 to $700 per month for a statin when the bioequivalent generic costs $4 at Walmart. If your Part D plan is placing any statin on a high tier, request a formulary exception or compare plans during open enrollment (October 15 to December 7) using the Medicare Plan Finder at medicare.gov.
Medicare beneficiaries who also qualify for Medicaid (dual-eligible or dual-special needs plan enrollees) typically pay $0 to $4 for generic statins under the Extra Help (Low-Income Subsidy) program. Applying for Extra Help can be done through the Social Security Administration at ssa.gov/extrahelp or at your local Social Security office. Most dual-eligible Medicare patients pay nothing for generic statins all year.
Common Statins Comparison Billing Errors
If your hospital bill shows $50 or more per statin tablet, or if your pharmacy bill for a generic statin exceeds $30 per month, check for these common billing errors before paying:
- Brand Lipitor or Crestor billed when the generic was actually dispensed: brand substitution errors add $300 to $700 per month to your bill. Always confirm the dispensed NDC on your receipt matches the generic.
- Wrong formulary tier applied by the pharmacy: if your Part D plan shows a statin at Tier 3 or higher copay but it should be Tier 1, the pharmacy may have keyed an incorrect drug code. Ask the pharmacist to reprocess the claim.
- Inpatient charge for a dose held per clinical order: statins are sometimes held before a surgical procedure or when a patient is on a restricted diet. If the dose was held but still billed, this is a dispute item.
- High-dose strength billed when a lower dose was ordered: atorvastatin 80 mg billed when 40 mg was ordered can double the per-tablet charge.
- Prior authorization denial not appealed: if commercial insurance denied statin coverage claiming non-formulary status, and your prescriber's office did not file an appeal, you may be paying cash unnecessarily. Generic statins are covered by nearly every plan.
Frequently Asked Questions
What is the cheapest statin in 2026?
Generic atorvastatin (Lipitor) and generic simvastatin (Zocor) are both available for $4 per month at Walmart through the $4 Generic Prescription Program, with no insurance required. Generic rosuvastatin (Crestor) is available for $4 to $9 at most major chains with a free GoodRx coupon. All three are therapeutically effective for lowering LDL cholesterol. Atorvastatin is the most commonly prescribed because it offers strong LDL reduction at a $4 price point. If you are paying more than $25 per month for any generic statin, show your pharmacist a free GoodRx coupon from goodrx.com.
Is there a generic for Lipitor, Crestor, and Zocor?
Yes. All three major brand-name statins have FDA-approved bioequivalent generics. Generic atorvastatin (Lipitor) has been available since November 2011. Generic simvastatin (Zocor) has been available since 2006. Generic rosuvastatin (Crestor) has been available since 2016 after AstraZeneca's last patents expired. As of 2026, more than 20 manufacturers produce generic atorvastatin and over 15 produce generic rosuvastatin. There are no biologics or biosimilars for any statin because statins are small-molecule synthetic drugs, not biologics.
How do I apply for the patient assistance program for Lipitor or Crestor?
For brand Lipitor, apply through Pfizer RxPathways at pfizerrxpathways.com or call 1-844-989-PATH (7284). For brand Crestor, apply through AstraZeneca's AZ&Me program at azandme.com or call 1-800-292-6363. Both programs require household income at or below 300 percent of the federal poverty level, a valid prescription, and proof of no commercial drug insurance. Processing takes 7 to 14 business days. For most patients, the generic statin at $4 to $15 per month is a faster and simpler alternative than applying for a PAP.
Can I use a Lipitor or Crestor manufacturer coupon with Medicare?
No. Federal anti-kickback statute (42 U.S.C. Section 1320a-7b) prohibits manufacturer savings cards from being used by anyone enrolled in Medicare, Medicaid, TRICARE, or VA benefits. Manufacturer copay cards for brand Lipitor and Crestor are for commercially insured patients only. If you are on Medicare and cannot afford your statin copay, you have two options: switch to the $4 to $15 generic (which should have a $0 to $5 copay on nearly every Part D plan), or apply for the income-based manufacturer PAP if you need the brand for a documented clinical reason.
Does Medicare Part D cover statins?
Yes. Medicare Part D covers all three generic statins (atorvastatin, rosuvastatin, simvastatin) on Tier 1 or Tier 2 with $0 to $5 monthly copays. The statins are not subject to IRA price negotiation because they are already generic and inexpensive. Your total annual out-of-pocket spending for all Part D drugs is capped at $2,100 in 2026 by the Inflation Reduction Act of 2022. If your Part D plan is placing a statin on Tier 3 or higher, request a formulary tier exception during your plan's coverage year.
What if my insurance denies statin coverage?
Generic statin coverage denials are rare because every Part D plan and most commercial plans cover at least two statins on Tier 1. If denied, request a written denial notice, then ask your prescriber to file a prior authorization or formulary exception. Most denials for generic statins are reversed quickly. If your plan requires a different statin first under step therapy, your prescriber can file a step-therapy override documenting why the required statin is not appropriate. While appealing, the $4 Walmart generic provides immediate access at minimal cost.
Do I qualify for the Pfizer RxPathways or AZ&Me patient assistance program?
To qualify for Pfizer RxPathways for Lipitor, you must have household income at or below 300 percent of the federal poverty level in 2026, a valid Lipitor prescription, and no commercial prescription drug insurance. For a single-person household, 300 percent FPL is $47,880 per year. For a family of four, the threshold is $99,000. AZ&Me for Crestor uses the same 300 percent FPL threshold for primary care products. Commercially insured patients are not eligible for either program. Most patients can use the $4 to $15 generic instead and bypass the PAP application entirely.
Which statin is best: Lipitor, Crestor, or Zocor?
Clinical guidelines from the American College of Cardiology recommend choosing a statin based on the LDL reduction target, not the brand name. Atorvastatin and rosuvastatin are the two preferred high-intensity statins. At maximum doses, rosuvastatin (40 mg) typically lowers LDL by 55 to 63 percent, and atorvastatin (80 mg) by 49 to 57 percent. Simvastatin carries an FDA warning against the 80 mg dose due to myopathy risk, so it is now primarily used at lower doses for moderate-intensity therapy. For most patients, generic atorvastatin at $4 per month is the cost-effective first choice. Rosuvastatin is preferred for patients with drug interactions on the cytochrome P450 3A4 pathway or who need maximum LDL reduction. Ask your prescriber which statin intensity and dose matches your cardiovascular risk target.
